Parkwood Institute Main Building

London, Ontario N6C0A7

1 studies enrolling now · 2 studies all time

What they study most

Alzheimers Disease, Early Preclinical Alzheimer's Disease, Preclinical Alzheimer's Disease

Studies at this site

• A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease — Recruiting now
• AHEAD 3-45 Study: A Study to Evaluate Efficacy and Safety of Treatment With Lecanemab in Participants With Preclinical Alzheimer's Disease and Elevated Amyloid and Also in Participants With Early Preclinical Alzheimer's Disease and Intermediate Amyloid — Running, not enrolling